Get regular updates to your inbox.
The sense of physical fatigue and perceived fatigability, or the impact of reduced physical performance on daily life activities, are frequent and disabling symptoms in adults with spinal muscular atrophy (SMA) at different functional levels, a study showed. Such symptoms — whose frequency was generally associated with motor impairment —…
Doctors expected Stephen Mikita to live for six months after his diagnosis, in the late 1950s, with spinal muscular atrophy (SMA) type 2. Now 66, Mikita can look back on a successful career in law, first as a law clerk to the late U.S. Sen. Orrin Hatch, a…
Kevin,….Way to go…..terrific article…….
The relationship between a physical therapist and patient is very important for many reasons and should be an open, honest, and trusting relationship. This is especially important when you are working with someone with SMA, or another neurological disorder, who you will most likely be seeing long-term. It is important…
Newborn screening for spinal muscular atrophy (SMA) leads to better outcomes, with babies being diagnosed earlier and with prompt access to life-saving treatments, according to three-year data from the SMA screening program in the state of New York. Gene therapy was the main treatment strategy, and delays in…
Thank you Joanne! I pray that God meets all of Zack and your needs as well. Blessings!…
Ari, you have been through it! We will continue to pray that all goes well with your respiratory status and the next procedure to get rid of the rest of the stones. Blessings to you!…
Higher levels of the glial fibrillary acidic protein (GFAP) in the fluid around the brain and spinal cord are associated with poorer motor function among people with spinal muscular atrophy (SMA), a new study reports. These results indicate that cells called astrocytes are more active in advanced SMA,…
In the first year of a newborn screening program for spinal muscular atrophy (SMA) in Japan, more than 10,000 babies were screened and one tested positive for the disease, according to a new study. The baby with SMA was able to receive the gene therapy Zolgensma (onasemnogene…
Compared to what would be expected without treatment, the approved oral therapy Evrysdi (risdiplam) led to marked benefits in survival and motor outcomes for babies with spinal muscular atrophy (SMA) type 1, according to a comparison of clinical trial data. “Untreated infants with Type 1 SMA ……
Get regular updates to your inbox.